Drug Price Trends for NDC 00472-0478

Average Pharmacy Cost for 00472-0478

Drug Name	NDC	Price/Unit ($)	Unit	Date
DESOXIMETASONE 0.25% CREAM	00472-0478-60	0.30568	GM	2025-03-19
DESOXIMETASONE 0.25% CREAM	00472-0478-15	0.47749	GM	2025-03-19
DESOXIMETASONE 0.25% CREAM	00472-0478-60	0.29621	GM	2025-02-19
DESOXIMETASONE 0.25% CREAM	00472-0478-15	0.47742	GM	2025-02-19
DESOXIMETASONE 0.25% CREAM	00472-0478-60	0.26307	GM	2025-01-22

Best Wholesale Price for NDC 00472-0478

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for Drug NDC: 00472-0478

The pharmaceutical industry is constantly evolving, with market dynamics and pricing strategies playing crucial roles in shaping the future of drug accessibility and profitability. In this comprehensive analysis, we'll delve into the market trends and price projections for the drug with National Drug Code (NDC) 00472-0478, examining various factors that influence its positioning in the healthcare landscape.

Understanding the National Drug Code (NDC) System

Before we dive into the specifics of NDC 00472-0478, it's essential to understand the NDC system itself. The NDC is a unique, three-segment number assigned by the Food and Drug Administration (FDA) to human drugs in the United States[9]. This universal product identifier serves as a crucial tool for various stakeholders in the pharmaceutical supply chain.

The Structure of NDC Numbers

The NDC consists of three segments:

1. Labeler Code: Assigned by the FDA to the drug manufacturer, repacker, or distributor.
2. Product Code: Identifies the specific strength, dosage form, and formulation of the drug.
3. Package Code: Indicates the package size and type.

For NDC 00472-0478, we can break it down as follows:

• Labeler Code: 00472
• Product Code: 047
• Package Code: 8

Significance of NDC in Drug Identification

The NDC plays a vital role in various aspects of the pharmaceutical industry, including:

• Drug safety and recall management
• Inventory control and supply chain management
• Billing and reimbursement processes
• Electronic health record systems

Market Trends Affecting NDC 00472-0478

To accurately analyze the market for NDC 00472-0478, we must consider the broader trends shaping the pharmaceutical industry in 2025 and beyond.

Shift Towards Personalized Medicine

One of the most significant trends in the pharmaceutical industry is the move towards personalized medicine. This approach tailors treatments to individual patients based on their genetic makeup, lifestyle, and environmental factors.

"Across the health ecosystem, value creation is moving in the direction of prevention, with more focus on addressing the risk factors of health decline; personalization, with data-driven, customized treatments based on factors like genetics and behavior; prediction, with active analysis of well-being and early intervention to improve health outcomes and point of care, with more accessible and convenient settings for delivery of care."[3]

This trend could potentially impact NDC 00472-0478, depending on its therapeutic category and target patient population.

Technological Advancements in Drug Development

The integration of artificial intelligence (AI) and machine learning in drug development is accelerating research and reducing costs. According to industry experts, "85% of biopharma executives say they plan to invest in data, digital and AI in R&D for 2025"[7]. This could lead to more efficient production processes and potentially lower costs for drugs like NDC 00472-0478.

Focus on High Unmet Medical Needs

Pharmaceutical companies are increasingly shifting their focus to therapy areas with high unmet needs. As noted in recent industry reports, "about half of the 10 largest pharma companies focusing on TAs beyond core areas such as oncology and immunology"[7]. Depending on its therapeutic application, NDC 00472-0478 could benefit from this trend if it addresses a significant unmet medical need.

Price Projections for NDC 00472-0478

Predicting drug prices is a complex task influenced by numerous factors. However, we can make informed projections based on current trends and available data.

Historical Price Trends

While we don't have specific historical data for NDC 00472-0478, we can look at general trends in drug pricing. According to recent data, "the median price increase for generic drugs was 20% in 2022, while brand name drugs saw a median increase of 14.9%"[6]. This suggests that regardless of whether NDC 00472-0478 is a brand-name or generic drug, it's likely to see some level of price increase in the coming years.

Impact of Medicare Drug Price Negotiation Program

The implementation of the Medicare Drug Price Negotiation Program is expected to have a significant impact on drug pricing in the United States. As stated in a recent CMS factsheet:

"The savings realized through the negotiation process are expected to lower out-of-pocket costs for Medicare enrollees by an estimated $1.5 billion"[10]

If NDC 00472-0478 is among the drugs selected for negotiation, it could see price reductions in the Medicare market, which may influence its overall market pricing strategy.

Supply Chain Optimization

Pharmaceutical companies are increasingly focusing on optimizing their supply chains to reduce costs and improve resilience. Industry reports indicate that "More than 85% of biopharma executives we surveyed say they are investing in data, AI and digital tools in 2025 to build supply chain resiliency"[7]. These efforts could potentially lead to cost savings that might be reflected in the pricing of drugs like NDC 00472-0478.

Factors Influencing Price Setting for NDC 00472-0478

Several key factors are likely to influence the pricing strategy for NDC 00472-0478:

Patent Status

The patent status of a drug significantly impacts its pricing. If NDC 00472-0478 is a brand-name drug still under patent protection, it's likely to maintain higher prices. However, if it's nearing patent expiration or is already a generic drug, pricing pressures may increase.

Competition in the Market

The level of competition in the therapeutic area of NDC 00472-0478 will play a crucial role in its pricing. Increased competition typically leads to downward pressure on prices.

Production Costs

As pharmaceutical companies invest in advanced manufacturing technologies and supply chain optimization, production costs may decrease. This could potentially allow for more competitive pricing of NDC 00472-0478.

Regulatory Environment

Changes in healthcare policies and regulations can significantly impact drug pricing. For instance, the implementation of the Medicare Drug Price Negotiation Program could lead to price reductions for selected drugs[10].

Market Positioning Strategies for NDC 00472-0478

To maintain a competitive edge in the market, the manufacturer of NDC 00472-0478 may consider the following strategies:

Value-Based Pricing

Implementing a value-based pricing model that ties the drug's cost to its clinical effectiveness and patient outcomes could help justify its price point and improve market access.

Targeted Marketing

Focusing marketing efforts on the specific patient population that benefits most from NDC 00472-0478 can help establish its unique value proposition in the market.

Strategic Partnerships

Collaborating with healthcare providers, payers, and patient advocacy groups can help build support for NDC 00472-0478 and potentially improve its market position.

Future Outlook for NDC 00472-0478

The future market performance of NDC 00472-0478 will depend on various factors, including its therapeutic efficacy, pricing strategy, and ability to adapt to changing market conditions.

Potential for Market Expansion

If NDC 00472-0478 demonstrates superior efficacy or addresses an unmet medical need, it may have opportunities for market expansion, potentially leading to increased sales volume and revenue.

Pricing Pressures

As healthcare systems worldwide grapple with rising costs, pricing pressures on pharmaceuticals are likely to continue. NDC 00472-0478 may need to demonstrate clear value to maintain its market position and pricing.

Technological Advancements

Ongoing advancements in drug development and manufacturing technologies could impact the production and delivery of NDC 00472-0478, potentially affecting its cost structure and market competitiveness.

Key Takeaways

• The pharmaceutical market is evolving rapidly, with trends towards personalized medicine, technological advancements, and focus on high unmet medical needs shaping the industry.
• Drug pricing is influenced by multiple factors, including patent status, competition, production costs, and the regulatory environment.
• The Medicare Drug Price Negotiation Program could significantly impact drug pricing in the U.S. market.
• Market positioning strategies such as value-based pricing, targeted marketing, and strategic partnerships can help maintain competitiveness.
• The future outlook for NDC 00472-0478 will depend on its ability to demonstrate value, adapt to market changes, and leverage technological advancements.

FAQs

1. Q: How does the NDC system impact drug pricing? A: The NDC system itself doesn't directly impact drug pricing, but it plays a crucial role in drug identification, which can indirectly influence pricing through improved supply chain management and billing processes.

2. Q: What role does AI play in drug development and pricing? A: AI is increasingly used in drug development to accelerate research and reduce costs. This could potentially lead to more efficient production processes and impact drug pricing strategies.

3. Q: How might the Medicare Drug Price Negotiation Program affect NDC 00472-0478? A: If NDC 00472-0478 is selected for negotiation under this program, it could see price reductions in the Medicare market, which may influence its overall pricing strategy.

4. Q: What are the key factors that could lead to price increases for NDC 00472-0478? A: Factors that could lead to price increases include production cost increases, limited competition in its therapeutic area, and demonstrated superior efficacy compared to alternatives.

5. Q: How can pharmaceutical companies balance pricing pressures with the need for profitability? A: Companies can balance these pressures by implementing value-based pricing models, optimizing production processes, and clearly demonstrating the unique value proposition of their drugs to justify pricing decisions.

Sources cited: [3] https://www.pwc.com/us/en/industries/pharma-life-sciences/pharmaceutical-industry-trends.html [6] https://www.drugpatentwatch.com/p/drug-price/ndc/00430-0472 [7] https://www.zs.com/insights/pharmaceutical-trends-2025-outlook-ai-supplychain-and-beyond [9] https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information [10] https://www.cms.gov/files/document/factsheet-medicare-negotiation-selected-drug-list-ipay-2027.pdf